Funding This study, the Rapid Service and Open Access Fees (ClinicalTrials.gov: NCT03288740) were funded by Novo Nordisk A/S, Denmark
composition in mM: 2.5 KCl, 200 sucrose, 28 NaHCO 3 , 1.25 NaH 2 PO 4 , 8 glucose, 7 MgCl 2 , 0.5 CaCl 2
Choline contributes to normal lipid metabolism
Start by patch testing on a small area of skin for 24-48 hours
Diabetes 65 , 15771589 (2016)
A novel triple therapy, retatrutide, could continue the string of game-changing metabolic agents that began with semaglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist for type 2 diabetes and obesity, and continued with tirzepatide, a dual GLP-1/glucose-dependent insulinotropic polypeptide (GIP) receptor agonist